期刊文献+

血浆致动脉粥样硬化指数与2型糖尿病患者大血管病变的关系 被引量:11

Relationship Between Atherogenic Index of Plasma and Cardiovascular Disease with Type 2 Diabetes
下载PDF
导出
摘要 目的探讨血浆致动脉粥样硬化指数(AIP)与2型糖尿病(T2DM)患者大血管病变的关系。方法选择90例2型糖尿病患者与20例正常对照者,2型糖尿病患者按有无大血管并发症分成两组测量身高、体重,计算体重指数(BMI),测量血压、血脂,计算AIP(指TG/HDL-C比值的对数值),并进行统计学处理。结果与正常对照组比较,T2DM组呈现出TG升高,HDL-C降低,AIP值明显升高,其中,AIP值变化最明显(P<0·001);T2DM组中,有大血管并发症与无大血管并发症相比,大血管并发症组BMI、TG、TC、HDL-C、LDL-C、AIP差异有显著性(P<0·05),其中,AIP值差异最显著(P<0·001)。结论AIP间接反映LDL-C颗粒直径的大小,可作为2型糖尿病患者发生大血管并发症危险性的一个指标。 Objective To investigate the relationship between atherogenic index of plasma and cardiovascular disease with type 2 diabetes. Methods Ninty type 2 diabetic patients and twenty healthy subjects were recruited. The patient with T2DM were divided into two groups based on with or without cardiovascular complications. Atherogenic index was defined as the Log value of TG/HDL-C ratio. Results In T2DM group plasma triglyceride (TG) and AIP were significantly higher than those in control group, and HDL-C was significantly lower. In the cohort of diabetic subjects, the value of BMI, TG, TC, LDL- C, AIP in patients complicated cardiovascular disease were significantly higher than those without complications. Conclusion AIP value, an indirect indicator of LDL particle size may serve as an risk marker for cardiovascular disease in patients of T2DM.
出处 《高血压杂志》 CAS CSCD 北大核心 2006年第1期43-45,共3页 Chinese Journal of Hypertension
关键词 血浆致动脉粥样硬化指数 甘油三酯 高密度脂蛋白胆固醇 低密度脂蛋白胆固醇 2型糖尿病 Atherogenic index of plasma Triglyceride(TG) High density lipoprotein-cholesterol{ HDL-C} Low density lipoprotein-cholesterol( LDL-C) Type 2 diabetes
  • 相关文献

参考文献10

  • 1Dobiasova M, Frohlich J. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate; changes during lipemia therapy[J]. Vnitr Lek,2000,46:152-156.
  • 2Curhan GC, Willett WC, Rimm EB, et al. Family history and risk of kidney stones[J]. J Am Soc Nephrol, 1997,8: 1568-1573.
  • 3雷闽湘 廖二元 廖二元 超楚生 主编.糖尿病心脑血管病变[A].廖二元,超楚生,主编.内分泌学[M]第1版[C].北京:人民卫生出版社,2003.1574.
  • 4Temeikova Kurktsehiv TS, Henkel E, KolhlerC, et al. Increased intimal medial thickness in newly detected type 2 diabetes[J]. Diabetes Care, 1999,22: 333-338.
  • 5LehtoS, Ronnemaa T, HaffnerS, et al. Dyslipidema and hyperglycemia predict coronary heart disease events in middle-age patients with NIDDM[J]. Diabetes, 1997,48:354-359.
  • 6戴军,苏宜香,凌文华,梁亦铨,钟春宁,欧香忠.脂肪负荷餐中脂肪酸构成比的探讨[J].中国动脉硬化杂志,2000,8(3):251-255. 被引量:10
  • 7Lamarche B, Tchernof A, Moorjani S, et al. Small, dense lowdensity lipoprotein particles as a predictor of the risk of ischemic heart disease in men:prospective results from the Quebec cardiovascular study[J]. Circulation, 1997,95: 69-75.
  • 8SteinerG, StewartD, Hosking JD, et al. Base characterics of the study population in the diabetes atherosclerosis intervention study[J]. Am J Cardiol,1999,84:1004-1009.
  • 9Boize JR, Laporte F, Benhamou PY, et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels[J]. Diabetes Care,2000,23: 1679-1685.
  • 10胡耀敏,田浩明,刘瑞,陈香.血浆致动脉硬化指数与2型糖尿病患者颈动脉内膜中层厚度的相关性研究[J].四川大学学报(医学版),2004,35(5):696-698. 被引量:16

二级参考文献12

  • 1张新华 周北凡 等.人体测量方法.心血管病流行病学调查方法手册[M].北京:北京医科大学中国协和医科大学联合出版社,1997.64-66.
  • 2Boquist S,Circulation,1999年,100卷,7期,723页
  • 3张新华,心血管病流行病学调查方法手册,1997年,64页
  • 4Pan W H,Atherosclerosis,1995年,118卷,2期,285页
  • 5Chen J,JAOAC Int,1993年,76卷,6期,1206页
  • 6Dobiasova M, Frohlich J. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy. Vnitr Lek,2000;46(3):152.
  • 7Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-c) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clinical Biochemistry,2001;34(7):583.
  • 8Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation,1990;82(2):495.
  • 9Steinberb D,Parthasarathy S,Crew TE, et al.Modification of low density lipoprotein that increased its atherogenicity.New Eng J Med,1989;320(14):915.
  • 10Hunt JV,Bottoms MA,Clare K, et al.Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation; possible implications for diabetic atherosclerosis.Biochem J,1994;300(1):243.

共引文献24

同被引文献69

引证文献11

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部